Physicians' Academy for Cardiovascular Education

Why should cardiologist be concerned about cardio metabolic risk?

Slides (presentation) - June 18, 2011

Why should cardiologist be concerned about cardio metabolic risk?

Prof. D John Betteridge,
Emeritus Professor of Endocrinology and Metabolism UCL
Associate Dean Royal Society of Medicine, Consultant Physician, University College London Hospitals


To view presentation, click on slides below


Intra-Abdominal (Visceral) Fat
Abdominal obesity:
High waist circumference
Slide 5
The Metabolic Syndrome:
Increased CAD Events in Metabolic Syndrome
Adipose Tissue: A Major Secretory Organ
Dyslipidaemia in Type 2 Diabetes and Metabolic Syndrome
Characteristics of LDL Subclasses
The Absolute Concentration of LDL-C C
LDL Subfractions “Control” vs Patient with Insulin Resistance
UKPDS: Risk Factors for MI.
CHD Prevention Trials with Statins in Diabetic Patients Subgroup Analyses.
Time to First Major Cardiovascular Event Patients With Diabetes TNT Study
Acute Coronary Syndromes and Diabetes.
Implications of Recent Trials Adult Treatment Panel III Guidelines Diabetes
TNT Study
TNT Time to First Major Cardiovascular Event Patients With Metabolic Syndrome
CARDS: Collaborative AtoRvastatin Diabetes Study
Median Lipid Levels by Treatment
Median Lipid Levels by Treatment
CARDS
Treatment Effect on Primary Endpoint in CARDS
Cumulative Hazard for Stroke
Cumulative Hazard for Primary Endpoint in Older People
Joint British Societies’ Guidelines
CARDS: Safety Overview
CARDS: Safety Overview
CARDS: Safety Overview Muscle-related Adverse Events
CARDS: Safety Overview Muscle-related Adverse Events

Download teaching slides



Share this page with your colleagues and friends: